机译:局部和EGFR-TKI治疗的最佳序列与脑转移脑转移的脑转移中的EGFR-突变体非小细胞肺癌治疗
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Clin Res Ctr Shizuoka Japan;
Shizuoka Canc Ctr Div Radiat Therapy Shizuoka Japan;
Shizuoka Canc Ctr Div Neurosurg Shizuoka Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
Shizuoka Canc Ctr Div Diagnost Radiol Shizuoka Japan;
Shizuoka Canc Ctr Div Neurosurg Shizuoka Japan;
Nihon Univ Sch Med Div Resp Med Tokyo Japan;
Shizuoka Canc Ctr Div Thorac Oncol 1007 Shimonagakubo Nagaizumi Shizuoka 4118777 Japan;
机译:局部和EGFR-TKI治疗的最佳序列与脑转移脑转移的脑转移中的EGFR-突变体非小细胞肺癌治疗
机译:EGFR突变状态分层脑转移患者全脑放射治疗和TKI的生存效应差异
机译:靶向治疗时代EGFR-突变体非小细胞肺癌脑转移治疗脑转移的范式转变
机译:小细胞肺癌患者脑转移和生存时间预测规则的确定
机译:诱导神经干细胞疗法治疗三阴性乳腺癌和脑转移
机译:一项回顾性队列研究比较了同时进行EGFR-TKI和全脑放疗与单纯EGFR-TKI作为一线治疗晚期EGFR突变的非小细胞肺癌伴脑转移的一线治疗的疗效:
机译:Egfr-突变体非小细胞肺癌中颅局局部治疗的临床价值与脑转移中脑转移中的临床价值及最佳时间